GFM
GF Fund Management Portfolio holdings
AUM
$4.97B
This Quarter Return
-4%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$4.26B
AUM Growth
-$362M
(-7.8%)
Cap. Flow
-$2.11M
Cap. Flow
% of AUM
-0.05%
Top 10 Holdings %
Top 10 Hldgs %
43.71%
Holding
683
New
46
Increased
475
Reduced
93
Closed
17
Top Buys
| 1 |
Philip Morris
PM
|
$43M |
| 2 |
Amazon
AMZN
|
$24.3M |
| 3 |
Palantir
PLTR
|
$16.8M |
| 4 |
Yum China
YUMC
|
$14.4M |
| 5 |
Hims & Hers Health
HIMS
|
$10.9M |
Top Sells
| 1 |
Pinduoduo
PDD
|
$40.6M |
| 2 |
NVIDIA
NVDA
|
$25.7M |
| 3 |
KE Holdings
BEKE
|
$14.3M |
| 4 |
Meta Platforms (Facebook)
META
|
$13.3M |
| 5 |
Coca-Cola
KO
|
$9.83M |
Sector Composition
| 1 | Technology | 42.51% |
| 2 | Consumer Discretionary | 16.26% |
| 3 | Communication Services | 14.17% |
| 4 | Healthcare | 7.8% |
| 5 | Consumer Staples | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Iovance Biotherapeutics
IOVA
$901M
| $26K | ﹤0.01% |
7,805
+1,405
| +22% | +$4.68K |
|
477
Embraer
ERJ
$11.2B
| $25.5K | ﹤0.01% |
+551
| New | +$25.5K |
|
478
Collegium Pharmaceutical
COLL
$1.21B
| $24.7K | ﹤0.01% |
826
+149
| +22% | +$4.45K |
|
479
Enliven Therapeutics
ELVN
$1.19B
| $24.6K | ﹤0.01% |
1,251
+225
| +22% | +$4.43K |
|
480
Geron
GERN
$893M
| $24.6K | ﹤0.01% |
15,480
+2,787
| +22% | +$4.43K |
|
|
NTST
481
NETSTREIT Corp
NTST
$1.72B
| $24.5K | ﹤0.01% |
1,545
+150
| +11% | +$2.38K |
|
|
JBGS
482
JBG SMITH
JBGS
$1.4B
| $24.5K | ﹤0.01% |
1,520
+38
| +3% | +$612 |
|
483
Spyre Therapeutics
SYRE
$1.03B
| $24.2K | ﹤0.01% |
1,502
+270
| +22% | +$4.36K |
|
484
Harrow
HROW
$1.37B
| $24.2K | ﹤0.01% |
911
+163
| +22% | +$4.34K |
|
485
10x Genomics
TXG
$1.74B
| $23.9K | ﹤0.01% |
2,739
+492
| +22% | +$4.3K |
|
|
ALEX
486
Alexander & Baldwin
ALEX
$1.41B
| $23.7K | ﹤0.01% |
1,376
+67
| +5% | +$1.15K |
|
487
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $23.6K | ﹤0.01% |
1,064
+191
| +22% | +$4.24K |
|
488
RLJ Lodging Trust
RLJ
$1.18B
| $23K | ﹤0.01% |
2,909
+92
| +3% | +$726 |
|
489
Pebblebrook Hotel Trust
PEB
$1.4B
| $22.9K | ﹤0.01% |
2,261
+71
| +3% | +$719 |
|
490
Vir Biotechnology
VIR
$732M
| $22.8K | ﹤0.01% |
3,526
+634
| +22% | +$4.11K |
|
|
XHR
491
Xenia Hotels & Resorts
XHR
$1.38B
| $22.5K | ﹤0.01% |
1,913
+60
| +3% | +$706 |
|
|
AIV
492
Aimco
AIV
$1.11B
| $22.4K | ﹤0.01% |
2,542
+244
| +11% | +$2.15K |
|
493
Grifois
GRFS
$6.89B
| $22.2K | ﹤0.01% |
3,123
+561
| +22% | +$3.99K |
|
|
GRAL
494
GRAIL, Inc. Common Stock
GRAL
$1.33B
| $22K | ﹤0.01% |
860
+161
| +23% | +$4.11K |
|
495
89bio
ETNB
$1.32B
| $21.9K | ﹤0.01% |
3,011
+542
| +22% | +$3.94K |
|
496
Nurix Therapeutics
NRIX
$758M
| $21.6K | ﹤0.01% |
1,814
+327
| +22% | +$3.89K |
|
497
Genmab
GMAB
$16.9B
| $21K | ﹤0.01% |
1,073
+193
| +22% | +$3.78K |
|
498
Zymeworks
ZYME
$1.14B
| $21K | ﹤0.01% |
1,763
+317
| +22% | +$3.78K |
|
499
Xeris Biopharma Holdings
XERS
$1.27B
| $21K | ﹤0.01% |
3,817
+687
| +22% | +$3.77K |
|
500
Empire State Realty Trust
ESRT
$1.35B
| $20.9K | ﹤0.01% |
2,669
+112
| +4% | +$876 |
|